Clinical Trial Update: Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

View source ↗

Summary

Clinical trial update evaluating the safety and efficacy of the CRE8 sirolimus-eluting stent for de novo coronary artery lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CRE8 Sirolimus-Eluting Stent (sirolimus-eluting stent)

Snippet

Sponsor: CID S.p.A. | Conditions: Coronary Artery Disease | Status: UNKNOWN